| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |